Paper41398138
Targeting RUNX1 Germline Variants: Agents Under Investigation.
Ghalamkari S and 5 others. Curr Hematol Malig Rep, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Targeting RUNX1 Germline Variants: Agents Under Investigation. Papers, record 41398138. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398138
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Core Binding Factor Alpha 2 Subunit | Major topic |
| Germ-Line Mutation | Major topic |
| Hematologic Neoplasms | Major topic |
| Myeloproliferative Disorders | Major topic |
| Humans | |
| Animals | |
| Molecular Targeted Therapy | |
| Signal Transduction | |
| Genetic Predisposition to Disease |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25114263 | Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects. | Blood | 2014 | https://conductscience.org/library/papers/25114263 | PubMed |
| 2 | 26165925 | Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells. | Cell Stem Cell | 2015 | https://conductscience.org/library/papers/26165925 | PubMed |
| 3 | 33283989 | CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33283989 | PubMed |
| 4 | 37435412 | Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation. | J Hematol | 2023 | https://conductscience.org/library/papers/37435412 | PubMed |
| 5 | 11675361 | A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies. | Blood | 2001 | https://conductscience.org/library/papers/11675361 | PubMed |
| 6 | 38661449 | Exagamglogene Autotemcel for Severe Sickle Cell Disease. | N Engl J Med | 2024 | https://conductscience.org/library/papers/38661449 | PubMed |
| 7 | 32208489 | RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML. | Blood Adv | 2020 | https://conductscience.org/library/papers/32208489 | PubMed |
| 8 | 36322931 | A RUNX1-FPDMM rhesus macaque model reproduces the human phenotype and predicts challenges to curative gene therapies. | Blood | 2023 | https://conductscience.org/library/papers/36322931 | PubMed |
| 9 | 19230772 | Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. | Lancet Oncol | 2009 | https://conductscience.org/library/papers/19230772 | PubMed |
| 10 | 21941284 | A decade of exploring the cancer epigenome - biological and translational implications. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21941284 | PubMed |
| 11 | 39822266 | Casgevy (exagamglogene autotemcel) and Lyfgenia (lovotibeglogene autotemcel) for individuals 12 years and older with sickle cell disease (SCD) and recurrent vaso-occlusive crises (VOC): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). | Genet Med Open | 2024 | https://conductscience.org/library/papers/39822266 | PubMed |
| 12 | 39822584 | Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy). | Hemasphere | 2025 | https://conductscience.org/library/papers/39822584 | PubMed |
| 13 | 29730354 | The nonreceptor tyrosine kinase c-Abl phosphorylates Runx1 and regulates Runx1-mediated megakaryocyte maturation. | Biochim Biophys Acta Mol Cell Res | 2018 | https://conductscience.org/library/papers/29730354 | PubMed |
| 14 | 39078402 | Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy. | Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39078402 | PubMed |
| 15 | 35797463 | Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. | Blood | 2022 | https://conductscience.org/library/papers/35797463 | PubMed |
| 16 | 38019014 | Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy. | Blood Adv | 2024 | https://conductscience.org/library/papers/38019014 | PubMed |
| 17 | 15164071 | Epigenetics in human disease and prospects for epigenetic therapy. | Nature | 2004 | https://conductscience.org/library/papers/15164071 | PubMed |
| 18 | 37464068 | Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo. | Leukemia | 2023 | https://conductscience.org/library/papers/37464068 | PubMed |
| 19 | 35131736 | RUNX1 overexpression triggers TGF-β signaling to upregulate p15 and thereby blocks early hematopoiesis by inducing cell cycle arrest. | Stem Cell Res | 2022 | https://conductscience.org/library/papers/35131736 | PubMed |
| 20 | 29296817 | RUNX1 regulates site specificity of DNA demethylation by recruitment of DNA demethylation machineries in hematopoietic cells. | Blood Adv | 2017 | https://conductscience.org/library/papers/29296817 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| RUNX1 | 861 | PubTator's text mining | https://conductscience.org/library/genes/861 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41398138
GET https://conductscience.org/api/papers/v1/41398138/references?page=2